These findings challenge the assumption that pharmacologic weight reduction through semaglutide may indirectly improve fertility outcomes [13], and instead raise the possibility of unintended effects when used prior to fertility-related care
The plaintiffs have alleged that manufacturer Novo Nordisk knew or should have known of the risks and failed to warn users of the potential risks of vision loss when taking the drugs
This approach allows researchers to explore synergies across multiple pathways, offering groundbreaking insights into managing metabolic disorders
They also make appetite control stronger as doses go up, which helps keep long-term results manageable
For those embarking on this journey, the key is informed decision-making, ethical research practices, and a commitment to scientific inquiry
Definitely my favorite doctor! Dr